暴露前预防和艾滋病毒发病率

IF 1.1 4区经济学 Q3 ECONOMICS

B E Journal of Economic Analysis & Policy Pub Date : 2023-09-14 DOI:10.1515/bejeap-2023-0087

Samuel Mann

{"title":"暴露前预防和艾滋病毒发病率","authors":"Samuel Mann","doi":"10.1515/bejeap-2023-0087","DOIUrl":null,"url":null,"abstract":"Abstract Pre-Exposure Prophylaxis (PrEP) is a drug that, as demonstrated in clinical trials, when taken makes the user virtually immune to HIV. This has led to numerous countries making the drug available, but little is known about the population level effects of PrEP. Using panel data from 40 European countries I study the effect of countries adopting WHO recommendations to make PrEP available to citizens. I demonstrate that PrEP availability leads to around 15–20 % fewer new HIV infections. My results indicate that PrEP can be an effective tool in reducing HIV incidence.","PeriodicalId":47400,"journal":{"name":"B E Journal of Economic Analysis & Policy","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pre-Exposure Prophylaxis and HIV Incidence\",\"authors\":\"Samuel Mann\",\"doi\":\"10.1515/bejeap-2023-0087\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Pre-Exposure Prophylaxis (PrEP) is a drug that, as demonstrated in clinical trials, when taken makes the user virtually immune to HIV. This has led to numerous countries making the drug available, but little is known about the population level effects of PrEP. Using panel data from 40 European countries I study the effect of countries adopting WHO recommendations to make PrEP available to citizens. I demonstrate that PrEP availability leads to around 15–20 % fewer new HIV infections. My results indicate that PrEP can be an effective tool in reducing HIV incidence.\",\"PeriodicalId\":47400,\"journal\":{\"name\":\"B E Journal of Economic Analysis & Policy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2023-09-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B E Journal of Economic Analysis & Policy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1515/bejeap-2023-0087\",\"RegionNum\":4,\"RegionCategory\":\"经济学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B E Journal of Economic Analysis & Policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/bejeap-2023-0087","RegionNum":4,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ECONOMICS","Score":null,"Total":0}

引用次数: 0

摘要

暴露前预防(PrEP)是一种药物，正如临床试验所证明的那样，服用后使使用者几乎对艾滋病毒免疫。这导致许多国家提供了这种药物，但人们对PrEP对人口水平的影响知之甚少。我使用来自40个欧洲国家的小组数据研究了采用世卫组织建议向公民提供PrEP的国家的影响。我证明，提供预防措施可使艾滋病毒新发感染减少约15 - 20%。我的研究结果表明，PrEP可以成为降低艾滋病毒发病率的有效工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Pre-Exposure Prophylaxis and HIV Incidence

Abstract Pre-Exposure Prophylaxis (PrEP) is a drug that, as demonstrated in clinical trials, when taken makes the user virtually immune to HIV. This has led to numerous countries making the drug available, but little is known about the population level effects of PrEP. Using panel data from 40 European countries I study the effect of countries adopting WHO recommendations to make PrEP available to citizens. I demonstrate that PrEP availability leads to around 15–20 % fewer new HIV infections. My results indicate that PrEP can be an effective tool in reducing HIV incidence.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

B E Journal of Economic Analysis & Policy ECONOMICS-

CiteScore

1.50

自引率

11.10%

发文量

期刊介绍： The B.E. Journal of Economic Analysis & Policy welcomes submissions that employ microeconomics to analyze issues in business, consumer behavior, and public policy. We aim to be an international forum for scholarship, whether the scholarship considers an issue that is general or that pertains to a particular country or region, but authors should bear in mind that our readers come from around the world. Potential issues of interest include: the interaction of firms, the functioning of markets, the effects of domestic and international policy, and the design of organizations and institutions.